insights_auto
Why is LYEL up 3.00%?
Dive Deeperchevron_right
LYEL:NASDAQ
Lyell Immunopharma Inc
$8.23
arrow_upward
+3.00%(+0.24) 1D
Oct 15, 2:05:52 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for LYEL...
Open
$8.00
High
$8.44
Low
$7.76
Mkt. cap
201.68M
Avg. vol.
149.51K
Volume
213.20K
52-wk high
$45.00
52-wk low
$7.32
EPS
-$12.01
Beta
-0.03
Shares outstanding
24.50M
No. of employees
161
Open
$8.00
High
$8.44
Low
$7.76
Mkt. cap
201.68M
Avg. vol.
149.51K
Volume
213.20K
52-wk high
$45.00
52-wk low
$7.32
EPS
-$12.01
Beta
-0.03
Shares outstanding
24.50M
No. of employees
161
News stories
From web sources and news partners
ad-hoc-news.de
·
1 day ago
Lyell advances LYL273: what it means for Lyell Immunopharma stock
Profile
Lyell Immunopharma, Inc. is an American clinical-stage biopharmaceutical company headquartered in San Francisco, California. Founded in 2018, the company develops next-generation cell therapies, including CAR T cell, using technologies intended to improve T-cell persistence, function, and resistance to exhaustion. Its pipeline includes therapies being developed for hematologic malignancies and solid tumors. Wikipedia
About Lyell Immunopharma Inc
CEO-
Employees161
Founded2018
HeadquartersSouth San Francisco, California, United States
SectorBiotechnology
Websitelyell.com